DFTX financials
Definium Therapeutics (DFTX) financials: revenue, profit and margins by year and quarter, the balance sheet and cash flow.
DFTX income statement, yearly
| Year | Revenue | Gross profit | Operating income | Net income | EPS |
|---|---|---|---|---|---|
| 2025 | $0.00 | $0.00 | -$166.31M | -$183.79M | -2.06 |
| 2024 | $0.00 | -$527.00K | -$103.92M | -$108.68M | -0.15 |
| 2023 | $0.00 | -$3.16M | -$93.87M | -$95.73M | -2.44 |
| 2022 | $0.00 | $0.00 | -$66.33M | -$56.80M | -1.53 |
| 2021 | $0.00 | $0.00 | -$93.85M | -$93.04M | -3.40 |
| 2020 | $0.00 | $0.00 | -$33.03M | -$34.10M | -1.92 |